The Effect of Remote Ischemic Preconditioning in Aortic Valve Replacement Surgery

March 9, 2023 updated by: Pierre Voisine, Laval University

The Effect of Remote Ischemic Preconditioning in Aortic Valve Replacement Surgery : a Randomized Controlled Trial

The study objective is to verify if a non-invasive remote ischemic preconditioning procedure (blood pressure cuff on the arm) is cardioprotective when applied before an aortic valve replacement surgery.

Study Overview

Status

Active, not recruiting

Study Type

Interventional

Enrollment (Anticipated)

140

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Quebec City, Quebec, Canada, G1V 4G5
        • Hôpital Laval

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Planned isolated aortic valve replacement (stenosis based)
  • Age ≥ 18 years

Exclusion Criteria:

  • Pregnancy
  • Left ventricular dysfunction (LVEF< 50%)
  • Myocardial Infarct (< 7days)
  • Coronary artery disease (documented with >50% stenosis)
  • Coronary artery bypass grafting
  • Chronic renal insufficiency (creatinine >175 mmol/L or dialysis)
  • Endocarditis
  • Sternotomy redo
  • Deep vein thrombosis to the compressed limb
  • Emergency procedure
  • TAVI procedure
  • Planned off pump coronary artery bypass
  • MAZE procedure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group

Sham remote ischemic preconditioning on the right arm is induced with a blood pressure cuff inflation at 20 mm Hg for 5 min and followed by a 5 min reperfusion at 0 mm Hg. The sham ischemia-reperfusion cycle is performed 3 times for a total of 30 min. This procedure is done after anesthetic induction, but before the patient is placed on cardiopulmonary bypass.

A 20 mm Hg blood pressure cuff on the right arm does not induce ischemia.

Cuff pressure for ischemia sham is 20 mm Hg, ischemia is 200 mm Hg and reperfusion is 0 mm Hg
Experimental: Intervention group
Remote ischemic preconditioning on the right arm is induced with a blood pressure cuff inflation at 200 mm Hg for 5 min and followed by a 5 min reperfusion at 0 mm Hg. The ischemia-reperfusion cycle is performed 3 times for a total of 30 min. This procedure is done after anesthetic induction, but before the patient is placed on cardiopulmonary bypass.
Cuff pressure for ischemia sham is 20 mm Hg, ischemia is 200 mm Hg and reperfusion is 0 mm Hg

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in biochemical markers of myocardial ischemia
Time Frame: 6, 12, 24 and 48 hours post-operatively
Troponin T-HS and CK-MB concentration
6, 12, 24 and 48 hours post-operatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative complications
Time Frame: post-operatively until 30 days
Monitoring the safety of the strategy by monitoring post-operative complications
post-operatively until 30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 11, 2014

Primary Completion (Actual)

July 1, 2020

Study Completion (Anticipated)

December 1, 2024

Study Registration Dates

First Submitted

September 28, 2017

First Submitted That Met QC Criteria

October 3, 2017

First Posted (Actual)

October 9, 2017

Study Record Updates

Last Update Posted (Estimate)

March 10, 2023

Last Update Submitted That Met QC Criteria

March 9, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aortic Valve Stenosis

Clinical Trials on Blood pressure cuff inflation

3
Subscribe